Related Experiment Videos
Clinical consequences of under-recognized bipolar spectrum disorder
1Department of Psychiatry and Behavioral Sciences, Center for Anxiety and Depression, University of Washington School of Medicine, Seattle, WA 98105, USA. ddunner@uwashington.edu
Bipolar Disorders
|November 26, 2003
Summary
Bipolar spectrum disorders (BSD) are more common than previously thought, affecting up to 5% of people. Early screening for bipolar disorder and BSD is crucial for accurate diagnosis and effective treatment.
Area of Science:
- Psychiatry
- Mental Health Research
Background:
- Bipolar disorder prevalence is underestimated, especially when including bipolar spectrum disorders (BSD).
- Diagnosing bipolar II and BSD is challenging due to complexities in defining and diagnosing hypomania.
- Bipolar disorder and BSD are frequently misdiagnosed as unipolar depression due to overlapping symptoms.
Purpose of the Study:
- To highlight the significant prevalence of bipolar spectrum disorders (BSD).
- To emphasize the importance of recognizing and adequately treating bipolar disorder and BSD.
- To advocate for improved diagnostic strategies, including active screening for BSD.
Main Methods:
- Review of existing literature on bipolar disorder and bipolar spectrum disorders prevalence.
- Analysis of diagnostic challenges, particularly concerning hypomania and symptom overlap with unipolar depression.
- Discussion of the utility of screening tools like the Mood Disorders Questionnaire for early detection.
Main Results:
- The prevalence of bipolar disorder, particularly BSD, may approach 5%, higher than previously believed.
- Diagnostic difficulties stem from defining hypomania and symptom overlap with other psychiatric conditions.
- Active screening, using tools like the Mood Disorders Questionnaire, can improve recognition of BSD in patients presenting with depression.
Conclusions:
- Accurate recognition and treatment of bipolar disorder and BSD are essential due to their high personal, societal, and economic impact.
- Screening for BSD in patients with depressive symptoms is a viable strategy for improving diagnosis.
- Further research into treatments specifically for bipolar depression is warranted.